Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: Update on methods to reduce false tests

Journal of Inherited Metabolic Disease

Volumn 31, Issue SUPPL. 2, 2008, Pages

  La Marca, G ^a,c   Malvagia, S ^a   Casetta, B ^b   Pasquini, E ^a   Donati, M A ^a   Zammarchi, E ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Applied Biosystems   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; HEALTH CARE QUALITY; HUMAN; INBORN ERROR OF METABOLISM; ITALY; LABORATORY DIAGNOSIS; LIQUID CHROMATOGRAPHY; METHODOLOGY; NEWBORN; NEWBORN SCREENING; PREDICTIVE VALUE; PROGRAM DEVELOPMENT; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; INFANT, NEWBORN; ITALY; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY;

EID: 84855605163     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0965-z     Document Type: Article

References (26)

1. Bodamer OA, Hoffmann GF, Lindner M (2007) Expanded newborn screening in Europe (2007). J Inherit Metab Dis 30:439-444. doi:10.1007/s10545-007-0666-z.
2. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF (1993) Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 39:66-71.
3. Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49:1797-1817. doi:10.1373/clinchem.2003.022178.
4. Frazier DM, Millington DS, McCandless SE, et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76-85. doi:10.1007/s10545-006-0228-9.
5. Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE (2006) Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117:1915-1921. doi:10.1542/peds.2005-2294.
6. Heard GS, Secor McVoy JR, Wolf B (1984) A screening method for biotinidase deficiency in newborns. Clin Chem 30:125-127.
7. Jones PM, Bennett MJ (2002) The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry. Clin Chim Acta 324:121-128. doi:10.1016/S0009-8981 (02) 00238-3.
8. Khoury MJ, McCabe LL, McCabe ER (2003) Population screening in the age of genomic medicine. N Engl J Med 348:50-58. doi:10.1056/NEJMra013182.
9. La Marca G, Malvagia S, Donati MA, Morrone A, Pasquini E, Zammarchi E (2003) Rapid diagnosis of medium chain acyl Co-A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 17:2688-2692. doi:10.1002/rcm.1248.
10. La Marca G, Malvagia S, Funghini S, Pasquini E, Donati MA, Zammarchi E (2005a) Expanded newborn screening using tandem mass spectrometry in Tuscany. In: Proceedings of the 4th European Meeting of the International Society for Neonatal Screening. Paris, France, 5-6 September 2005, 29.
11. La Marca G, Malvagia S, Pasquini E, et al (2005b) Hyperhydroxyprolinaemia: a new case diagnosed during neonatal screening with tandem mass spectrometry. Rapid Commun Mass Spectrom 19:863-864. doi:10.1002/rcm.1861.
12. La Marca G, Malvagia S, Pasquini E, Innocenti M, Donati MA, Zammarchi E (2007) Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. Clin Chem 53:1364-1369. doi:10.1373/clinchem.2007.087775.
13. La Marca G, Malvagia S, Pasquini E, et al (2008) The inclusion of Succinylacetone as marker for Tyrosinemia type I in expanded newborn screening programs. Rapid Commun Mass Spectrom 22:812-818. doi:10.1002/rcm.3428.
14. Malvagia S, La Marca G, Casetta B, et al (2006) Falsely elevated C4-carnitine as expression of glutamate formiminotransferase deficiency in tandem mass spectrometry newborn screening. J Mass Spectrom 41:263-265. doi:10.1002/jms.964.
15. Millington DS, Kodo N, Norwood DL, Roe CR (1990) Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13:321-324. doi:10.1007/BF01799385.
16. Oglesbee D, Sanders KA, Lacey JM, et al (2008) Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clin Chem 54:542-549. doi:10.1373/clinchem.2007.098434.
17. Rhead WJ (2006) Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective. J Inherit Metab Dis 29:370-377. doi:10.1007/s10545-006-0292-1.
18. Sander J, Janzen N, Peter M, et al (2006) Newborn screening for hepatorenal tyrosinemia: tandem mass spectrometric quantification of succinylacetone. Clin Chem 52:482-487. doi:10.1373/clinchem.2005.059790.
19. Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399-1406. doi:10.1542/peds.111.6.1399.
20. Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1667-1724.
21. Scriver CR, Rosenberg LE (1973) Distribution of amino acids in body fluids. In: Scriver CR, Rosenberg LE, eds. Amino Acid Metabolism and Its Disorders. Philadelphia: WB Saunders, 39-60.
22. Stadler SC, Polanetz R, Maier EM, et al (2006) Newborn screening for β-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat 27:748-759. doi:10.1002/humu.20349.
23. Tan ES, Wiley V, Carpenter K, Wilcken B (2007) Non-ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening. Mol Genet Metab 90:446-448. doi:10.1016/j.ymgme.2006.11.010.
24. Tarini BA, Christakis DA, Welch HG (2006) State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics 118:448-456. doi:10.1542/peds.2005-2026.
25. Turgeon C, Magera MJ, Allard P, et al (2008) Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem 54:657-664. doi:10.1373/clinchem.2007.101949.
26. Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348:2304-2312. doi:10.1056/NEJMoa025225.